Skip to content

Optimization of Intraoperative Cell-level Fluorescence Scanning Strategy Based on Margin Risk Stratification in Breast-Conserving Surgery: A Prospective Study.

Optimization of Intraoperative Cell-level Fluorescence Scanning Strategy Based on Margin Risk Stratification in Breast-Conserving Surgery: A Prospective Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119358
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:Postoperative permanent paraffin pathology (H&E staining)
Index test:Interpretation of EndoSCell cell-level fluorescence scanning imaging based on margin risk stratification

Sponsors

Quanzhou first Hospital,Fujian
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Clinical Diagnosis:Patients with breast lesions highly suspicious of malignancy based on clinical examination and imaging (BI-RADS category >= 4). 2.Planned Procedure:Candidates for breast-conserving surgery (BCS) starting with intraoperative frozen section analysis. 3.Age: Female patients aged 18-75 years. 4.Consent: Voluntary signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Inflammatory breast cancer or extensive multicentric lesions unsuitable for breast-conserving surgery. 2.Previous history of ipsilateral breast surgery or radiotherapy. 3.Pregnant or lactating women. 4.Severe cardiac, pulmonary, hepatic, or renal dysfunction rendering the patient unable to tolerate surgery. 5.Known contraindications to the fluorescence imaging agents used in the study (e.g., related allergy risks). 6.Subjects with benign lesions confirmed by intraoperative frozen section.

Design outcomes

Primary

MeasureTime frame
Diagnostic Performance (Sensitivity, Specificity, Accuracy);Total Intraoperative Scanning Time;

Secondary

MeasureTime frame
Re-excision Rate;

Countries

China

Contacts

Public ContactChen Debo

Quanzhou first Hospital,Fujian

debochensr@163.com+86 595 2227 7011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026